(S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate, 98%, 250mg

(4R)-2,2-DIOXIDO-4-PHENYL-1,2,3-OXATHIAZOLIDINE, N-BOC PROTECTED, 95.0%, 100mg

2-(5-CHLOROPYRIDIN-3-YL)ACETONITRILE, 95%, 1g

3-Nitro-9H-fluoren-2-amine, 97%, 25mg

DIETHYL CYCLOPROPYLMALONATE, 95.0%, 250mg

Cubeta de muestra con tapa a presión, 5 ml, 25 Unidad(es)

1-(5-bromopyrimidin-2-yl)ethan-1-amine hydrochloride, 95%, 5g

3-Methylnonane>98.0%(GC)5mL

(S)-3,3,3-Trifluoro-1-phenyl-2-propylamine, 98.0%, 50mg

1-Methylimidazole Bis(trifluoromethanesulfonyl)imide>97.0%(HPLC)25g

(R)-2-((S)-2-CYCLOHEXYL-2-(PYRAZINE-2-CARBOXAMIDO)ACETAMIDO)-3,3-DIMETHYLBUTANOIC ACID, 97%, 250mg

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 5g

4,6-Dichloro-3-methyl-1H-pyrazolo[4,3-c]pyridine, 95.0%, 250mg